T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor ly-Reference-Cited by-同舟云学术

T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor ly

Published:2003-10 Issue:2 Volume:123 Page:309-322
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

D'Sa Shirley,Peggs Karl,Pizzey Arnold,Verfuerth Stephanie,Thuraisundaram Dharsha,Watts Michael,White Harry,Hale Geoff,Waldmann Herman,Goldstone Anthony,Mackinnon Stephen,Yong Kwee

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04612.x/fullpdf

Reference39 articles.

1. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning;Badros;Journal of Clinical Oncology,2002

2. Non-myeloablative stem cell transplants;Barrett;British Journal of Haematology,2000

3. Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma;Bellucci;Blood,2002

4. Structure and expression of human germline VH transcripts;Berman;Journal of Experimental Medicine,1991

5. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplantation;Blade;British Journal of Haematology,1998

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation;Expert Review of Clinical Immunology;2024-01-10

2. Anti-Relapse effects of donor natural killer cells and IL-2 gene modification on allogeneic hematopoietic stem cell transplantation in acute leukemia;Cancer Biomarkers;2020-10-09

3. CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen;British Journal of Haematology;2020-05-14

4. Donor T-cell responses and disease progression patterns of multiple myeloma;Bone Marrow Transplantation;2017-10-02

5. Immune Reconstitution After Hematopoietic Stem Cell Transplantation;Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist/Oncologist;2017-09-04